7 completed, 1 recruiting. 4 Phase 2, 2 Phase 3, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Immuncell-LC: new trials by email Literature Review of Immuncell-LC trials Research Report on Immuncell-LC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea Immuncell-LC, No Interventions - Hepatocellular Carcinoma | Completed | GC Cell Corporation | 230 | 2024-09-30 | 2025-08-15 | |
| Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer Immuncell-LC, Gemcitabine - Pancreatic Ductal Adenocarcinoma | Phase 3 | Recruiting | GC Cell Corporation | 408 | 2021-09-07 | 2021-11-22 |
| Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation Immuncell-LC - Liver Transplantation | Phase 1 / Phase 2 | Completed | GC Cell Corporation | 19 | 2019-01-24 | 2023-06-22 |
| Safety and Efficacy of "Immuncell-LC" in TACE Therapy Immuncell-LC - Carcinoma, Hepatocellular | Phase 2 | Completed | GC Cell Corporation | 76 | 2018-05-28 | 2023-06-22 |
| Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC Immuncell-LC - Advanced Hepatocellular Carcinoma | Phase 2 | Completed | GC Cell Corporation | 40 | 2013-12-01 | 2023-06-26 |
| A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma Activated T lymphocyte - Neuroblastoma | Not applicable | Completed | Seoul National University Hospital | 6 | 2013-02-01 | 2019-04-09 |
| Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer Activated T lymphocyte - Pancreatic Cancer | Phase 2 | Completed | GC Cell Corporation | 20 | 2009-09-01 | 2023-07-19 |
| Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients Immuncell-LC - Hepatocellular Carcinoma | Phase 3 | Completed | GC Cell Corporation | 230 | 2008-07-01 | 2023-07-11 |
Carcinoma, Hepatocellular (3) · Pancreatic Neoplasms (2) · Neuroblastoma (1)
GC Cell Corporation (7) · Seoul National University Hospital (1)
South Korea (8)
Jung Hwan Yoon, MD (2) · JinHee Kang (1) · Kyung Suk Suh, MD (1) · Sang Hyub Lee (1) · Siyoung Song, MD, PhD (1) · Soon Ho Um, MD, PhD (1)